Usefulness of drug patch testing in cutaneous drug allergy: What is new?

Revue Francaise d'Allergologie et d'Immunologie Clinique

Volumn 43, Issue 4, 2003, Pages 222-226

  Barbaud, A ^a  

^a SERVICE DE DERMATOLOGIE   (France)

Author keywords

Cutaneous adverse drug reaction; Drug allergy; Patch test

Indexed keywords

ACICLOVIR; AMOXICILLIN; BETA LACTAM ANTIBIOTIC; CARBAMAZEPINE; CEFCAPENE PIVOXIL; CEFDITOREN PIVOXIL; CEFETAMET PIVOXIL; CEFTERAM PIVOXIL; CIPROFLOXACIN; CODEINE; CORTICOSTEROID; COTRIMOXAZOLE; DIAZEPAM; DILTIAZEM; DIPYRONE; FAMCICLOVIR; HEPARIN DERIVATIVE; HYDROXYZINE; MORPHINE; NORFLOXACIN; NYSTATIN; PARACETAMOL; PIVMECILLINAM; PRISTINAMYCIN; PSEUDOEPHEDRINE; TEICOPLANIN; TETRAZEPAM; UNINDEXED DRUG; VALACICLOVIR;

ANAPHYLACTIC SHOCK; BULLOUS SKIN DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; CONTACT DERMATITIS; CROSS REACTION; DELAYED HYPERSENSITIVITY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DRUG ERUPTION; DRUG HYPERSENSITIVITY; ECZEMA; ERYTHEMA; FACE EDEMA; FEVER; HUMAN; HYPEREOSINOPHILIA; IMMEDIATE TYPE HYPERSENSITIVITY; INTRACUTANEOUS TEST; LICHENOID; LIVER DYSFUNCTION; PANCYTOPENIA; PAPULE; PATCH TEST; PIGMENT DISORDER; PRACTICE GUIDELINE; PRICK TEST; RASH; SIDE EFFECT; SKIN ALLERGY; TOXIC EPIDERMAL NECROLYSIS; URTICARIA;

EID: 0038538252     PISSN: 03357457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0335-7457(03)00099-6     Document Type: Conference Paper

References (25)

1. Barbaud A, Gonçalo M, Bruynzeel D, Bircher A. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 2001;45:321-8.
2. Barbaud A. Tests cutanés dans l'investigation des toxidermies: de la physiopathologie aux résultats des investigations. Thérapie 2002;57:258-62.
3. Klienhans M, Linzbach L, Zedlitz S, Kaufmann R, Boehncke WH. Positive patch test reactions to celecoxib may be due to irritation and do not correlate with the results of oral provocation. Contact Dermatitis 2002;47:100-2.
4. Lammintausta K, Mäkela L, Kalimo K. Rapid systemic valaciclovir reaction subsequent to aciclovir contact allergy. Contact Dermatitis 2001;45:181.
5. Barbaud A, Trechot P, Reichert-Penetrat S, Granel F, Schmutz JL. Drug patch testing: the usefulness in testing on the most previously affected site in a systemic cutaneous adverse drug reaction to tetrazepam. Contact Dermatitis 2001;44:259-60.
6. Romano A, Viola M, Mondino C, Pettinato R, Di Fonso M, Papa G, et al. Diagnosing nonimmediate reactions to penicillins by in vivo tests. Int Arch Allergy Immunol 2002;129:169-74.
7. Pollock B, Wilkinson SM, MacDonald Hull SP. Chronic urticaria associated with intra-articular methylprednisolone. Br J Dermatol 2001;144:1228-30.
8. Figarella I, Barbaud A, Lecompte T, De Maistre E, Reichert-Penetrat S, Schmutz JL. Réaction cutanée d'hypersensibilité retardée avec polysensibilisation aux héparines et héparinoïdes. Ann Dermatol Venereol 2001;128:25-30.
9. Britschgi M, Steiner UC, Schmid S, Depta JPH, Senti G, Bircher A, et al. T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest 2001;107:1433-41.
10. Estrada JL, Alvarez Puebla MJ, Ortiz de Urbina JJ, Matilla B, Rodriguez Priet MA, Gozalo F. Generalized eczema due to codeine. Contact Dermatitis 2001;44:185.
11. Sakakibara T, Hata M, Numano K, Kawase Y, Yamanishi Tkawana S, Tsuboi N. Fixed-drug eruption caused by allylisopropylacetylurea. Contact Dermatitis 2001;44:189-90.
12. Kawada A, Aragane Y, Maeda A, Asai M, Shiraishi H, Tezuka T. Drug eruption induced by cefcapene pivoxil hydrochloride. Contact dermatitis 2001;44:197.
13. Rodriguez-Morales A, Alonso Llamazares A, Palacios Benito R, Martinez Cocera C. Fixed drug eruption from quinolones with a positive lesional patch test to ciprofloxacin. Contact Dermatitis 2001;44:255.
14. Bernedo N, Gonzalez I, Gastaminza G, Audicana M, Fernandez E, Munoz D. Positive patch test in vancomycin allergy. Contact Dermatitis 2001;45:43.
15. Barranco R, Tornero P, De Barrio M, De Frutos C, Rodriguez A, Rubio M. Type IV hypersensitivity to oral nystatin. Contact Dermatitis 2001;45:60.
16. Gonzalo-Garijo MA, de Arila D, Rodriguez-Nevado I. Generalized reaction after patch testing with metamizol. Contact Dermatitis 2001;45:180.
17. Quinones Estevez D, Fernandez Schmitz C. Exanthema to metamizole. Allergy 2001;56:262-3.
18. Rebello S, Sanchez P, Vega JM, Sedano E, Sanchis ME, Asensio T, et al. Hypersensitivity syndrome from isoniazid with positive patch test. Contact Dermatitis 2001;45:306.
19. Sasaki K, Yamamoto T, Kishi M, Yokozeki H, Nishioka K. Acute exanthematous pustular drug eruption induced by mexiletine. Eur J Dermatol 2001;11:469-71.
20. Verbeiren S, Morant C, Charlanne H, Ajebbar K, Caron J, Modiano P. Toxidermie due au Celebrex avec test épicutané positif. Ann Dermatol Vénéréol 2002;129:203-5.
21. Sedrano E, Vega JM, Rebollo S, Callejo A, Asensio T, Almendros R. Delayed exanthema to non ionic contrast medium. Allergy 2001;56:1015-6.
22. Barbaud A, Reichert-Penetrat S, Trechot P, Jacquin-Petit MA, Ehlinger A, Noirez V, et al. The use of kin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 1998;139:49-58.
23. Strauss RM, Green ST, Gawkrodger DJ. Rifampicin allergy confirmed by an intradermal test, but with a negative patch test. Contact Dermatitis 2001;45:108.
24. Romano A, Di Fonso M, Artesani MC, Viola M,Adesi FB, Venuti A. Delayed hypersensitivity to cefotetan. Allergy 2001;56:260-1.
25. Barbaud A, Trechot P, Reichert-Penetrat S, Commun N, Schmutz JL. Relevance of skin tests with drugs in investigating cutaneous adverse drug reactions. Contact Dermatitis 2001;45:265-8.